Science favours J&J in talcum powder lawsuits

There is no evidence that women who use talcum powder are any more likely to get ovarian cancer than women who don't, says the writer.
There is no evidence that women who use talcum powder are any more likely to get ovarian cancer than women who don't, says the writer. PHOTO: REUTERS
New: Gift this subscriber-only story to your friends and family

If I ran a hedge fund - now there's a thought! - I would be loading up right now on shares of Johnson & Johnson. After rising nearly 25 per cent from the end of May until Dec 13, the stock suddenly plummeted, giving back almost all of the gains in five trading days. As 2018 comes to a close, it's down 9 per cent for the year.

The stock's abrupt drop was due to a Reuters story, published on Dec 14, which alleged that the company was aware its best-known product, its talcum powder, contained "small amounts of asbestos", and had kept that knowledge a secret.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.

A version of this article appeared in the print edition of The Straits Times on December 29, 2018, with the headline Science favours J&J in talcum powder lawsuits. Subscribe